Ocugen Inc (OCGN) Live Share Price, Invest From India

Ocugen Inc Stock Performance

as on December 9, 2025 at 12:36 am IST

Day's Low
Day's High
$1.18
Day's Price Range
$1.25
$1.19
0.84%
Downside
5.04%
Upside
52 Week's Low
52 Week's High
$0.52
52-Week Price Range
$1.9
$1.19
56.72%
Downside
59.66%
Upside

Ocugen Inc share price movements today

Previous Close: $1.22
Open: $1.23
Volume: 2.1M
Day's Low - High: $1.18 - $1.25
52 Week Low - High: $0.52 - $1.9

Ocugen Inc Historical Returns

1 Month Return: -10.29 %
3 Month Return: + 18.45 %
1 Year Return: + 40.23 %
3 Year Return: -12.86 %
5 Year Return: + 303.31 %

Ocugen Inc Stock Fundamentals & Key Indicators

Check Ocugen Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$381.0M

EPS (TTM)

-0.2275

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-57.5M

Revenue (TTM)

5.4M

Profit Margin

0.00%

Return On Equity TTM

-289.93%

Ocugen Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ocugen Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Ocugen Inc	BUY	$381.0M	303.31%	NA	0.00%
Insmed Incorporated	BUY	$43.5B	418.42%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	257.77%	1431.62	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$116.8B	98.18%	32.05	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$76.1B	44.5%	17.21	32.13%

Stock Returns calculator for Ocugen Inc Stock including INR - Dollar returns

The Ocugen Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Ocugen Inc investment value today

Current value as on today

₹1,42,921

Returns

₹42,921

(+42.92%)

Returns from Ocugen Inc Stock

₹36,782 (+36.78%)

Dollar Returns*

₹6,139 (+6.14%)

Analyst Recommendation on Ocugen Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Ocugen Inc. Average target price of $9

Ocugen Inc Share Price Target

Get share price movements and forecasts by analysts on Ocugen Inc.

What analysts predicted

86.78%UPSIDE

Target Price

Current Price

$1.19

Analyzed by

9 Analysts

Target

$9.00

Ocugen Inc target price $9, a slight upside of 86.78% compared to current price of $1.19. According to 9 analysts rating.

Ocugen Inc Stock’s Investor Sentiment and Interest

Search interest for Ocugen Inc Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: November 9, 2025 to December 9, 2025

Change:-57% versus previous 30 day period

Ocugen Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	3	6	1	1	1	0	1	1	1
Gross Profit	-14	-3	5	1	1	1	0	1	1	1
Operating Income	-23	-12	-8	-12	-15	-13	-13	-14	-13	-17
EBITDA	-23	-12	-8	-12	-14	-12	-13	-13	-12	-17
Interest Expense	-	-	-	1	-	-	-	0	1	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-23	-11	-9	-11	-15	-12	-13	-15	-14	-20
Income Tax Expense	0	0	0	0	-	-	-	-	-	-
Net Income	-23	-11	-9	-11	-15	-12	-13	-15	-14	-20
Net Profit Margin	-4755.67%	-316.76%	-157.27%	-1175.94%	-1339.18%	-1141.73%	-1816.75%	-1036.46%	-1073.49%	-1144.46%

Ocugen Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	0	0	0	2	6	4
Gross Profit	-1	-1	0	-8	-6	0	-1	5	2
Operating Income	-30	-24	-30	-14	-21	-58	-84	-65	-54
EBITDA	-11	-24	-14	-14	-14	-57	-84	-64	-52
Interest Expense	0	0	0	1	0	0	3	-	-
Depreciation	-	1	0	0	0	0	0	0	1
Income Before Tax	-16	-26	-8	-20	-21	-58	-81	-63	-54
Income Tax Expense	-15	0	-15	0	0	0	-3	0	-
Net Income	-16	-26	-8	-20	-21	-58	-77	-63	-54
Net Profit Margin	0.00%	0.00%	0.00%	-47496.48%	-50748.84%	-254646.60%	-3128.38%	-1045.03%	-1333.02%

Ocugen Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-14	-9	-11	-15	-12	-13	-15	-14	-20
Operating Cash Flow	-13	-11	-10	-9	-11	-10	-19	-10	-12
Investing Cash Flow	-3	-	-2	0	0	0	0	0	0
Financing Cash Flow	0	0	0	0	34	30	-1	0	18
Change in Cash	-17	-14	-13	-10	23	19	-20	-10	5

Ocugen Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-16	-26	-8	-20	-21	-58	-86	-63	-54
Operating Cash Flow	-25	-23	-15	-16	-14	-47	-60	-62	-42
Investing Cash Flow	0	-1	-1	-2	0	-1	-16	3	-3
Financing Cash Flow	27	0	25	25	31	120	59	20	64
Change in Cash	0	-24	8	5	16	70	-17	-38	19

Global Institutional Holdings in Ocugen Inc

Funds	Holdings
Vanguard Group Inc	4.73%
BlackRock Inc	1.79%
Millennium Management LLC	1.62%
GMT Capital Corp	1.33%
Geode Capital Management, LLC	1.12%

See all

Insights on Ocugen Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 995.0% return, outperforming this stock by 1007.9%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 130.4%
NEGATIVE IMPACT
Price Dip
In the last 1 month, OCGN stock has moved down by -10.3%

About Ocugen Inc

ocugen, inc., is a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved ocular disorders. the company’s lead programs in ocular graft versus host disease (ocu300) and chronic dry eye disease (ocu310) are expected to enter pivotal clinical trials in 2018. ocu300 received the first and only orphan drug designation for ocular graft versus host disease, providing certain regulatory and economic benefits. ocugen is also developing novel biologic therapies for retinitis pigmentosa (ocu100) and wet amd (ocu200), as well as a groundbreaking modifier gene therapy platform with potential to address a broad spectrum of inherited retinal disorders (ocu400). for more information, please visit www.ocugen.com.

Organisation	Ocugen Inc
Headquarters	11 Great Valley Parkway, Malvern, PA, United States, 19355
Industry	Health Technology
CEO	Dr. Shankar Musunuri M.B.A., Ph.D.
E-voting on shares	Click here to vote

Key Management of Ocugen Inc

Name	Title
Dr. Vijay Tammara Ph.D.	Chief Development Officer
Ms. Jyothy Pillai M.S.	VP & Head of Regulatory & Quality
Dr. Huma Qamar CMI, M.D., M.P.H.	Chief Medical Officer
Mr. Ramesh Ramachandran C.M.A., CPA, M.B.A.	Chief Accounting Officer, Principal Financial Officer & Principal Accounting Officer
Ms. Kristen Craft	Head of People & Culture
John Kouch J.D.	General Counsel
Ms. Tiffany J. Hamilton M.B.A.	AVP & Head of Corporate Communications
Dr. Shankar Musunuri M.B.A., Ph.D.	Co-Founder, CEO & Chairman
Dr. Uday B. Kompella Ph.D.	Co-founder & Independent Director
Dr. Arun Upadhyay Ph.D.	Chief Scientific Officer and Head of Research & Development

FAQs

What is Ocugen Inc share price today?

Ocugen Inc share price today is $1.19 as on December 9, 2025 at 12:36 am IST. Ocugen Inc share today touched a day high of $1.25 and a low of $1.18.

What is the 52 week high and 52 week low for Ocugen Inc share?

Ocugen Inc share touched a 52 week high of $1.9 on October 3, 2025 and a 52 week low of $0.52 on March 19, 2025. Ocugen Inc stock price today i.e. December 9, 2025 at 12:36 am IST is trending at $1.19,which is 37.37% down from its 52 week high and 131.07% up from its 52 week low.

What is Ocugen Inc's market capitalisation today?

Ocugen Inc market capitalisation is $0.00T as on December 9, 2025 at 12:36 am IST.

How to invest in Ocugen Inc Stock (OCGN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ocugen Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ocugen Inc Shares that will get you 1.2605 shares as per Ocugen Inc share price of $1.19 per share as on December 9, 2025 at 12:36 am IST.

What is the minimum amount required to buy Ocugen Inc Stock (OCGN) from India?

Indian investors can start investing in Ocugen Inc (OCGN) shares with as little as ₹90.066 or $1 (as of December 9, 2025 at 12:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹900.66 in Ocugen Inc stock (as per the Rupee-Dollar exchange rate as on December 9, 2025 at 12:37 am IST). Based on Ocugen Inc share’s latest price of $1.19 as on December 9, 2025 at 12:36 am IST, you will get 8.4034 shares of Ocugen Inc. Learn more about fractional shares .

What are the returns that Ocugen Inc has given to Indian investors in the last 5 years?

Ocugen Inc stock has given 303.31% share price returns and 22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?